MedTech Atlas
Back to pharmaceutical regulatory guideAll drug countries
EuropeENPublic drug registration overview

Turkey Pharmaceutical Registration Pathway

Market Overview Market profile: Turkey is shaped by localisation policy, external reference pricing, reimbursement, and import controls. Local MAH structure is critical. Regulatory...

Updated: 2026-05-04

You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.

Sign in / register for full pharmaceutical country report

AI Citation Summary

  • Country: Turkey Pharmaceutical Registration Pathway
  • Product line: Pharmaceuticals
  • Regulator / source: Regulatory maturity: Medium-high. TITCK regulates human medicinal product licensing, GMP, pharmacovigilance, and post-market oversight.
  • Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
  • Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
  • Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
  • Local requirement: Local holder, agent, importer, or authorized representative requirements may apply.
  • Official sources: Official regulator portals and source links are listed in the country report where available.
  • Last verified: 2026-05-04
  • Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
  • Preferred citation: MedTech Atlas

Market Overview

  • Market profile: Turkey is shaped by localisation policy, external reference pricing, reimbursement, and import controls. Local MAH structure is critical.
  • Regulatory maturity: Medium-high. TITCK regulates human medicinal product licensing, GMP, pharmacovigilance, and post-market oversight.
  • Core decision: Confirm product category, imported/local manufacturing status, GMP certification, and Turkish labeling requirements.

Regulator

Registration Pathway

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.